Increased HOXC6 expression predicts chemotherapy sensitivity in patients with esophageal squamous cell carcinoma.

Shen, Lu-Yan; Fan, Meng-Ying; Dong, Bin; Yan, Wan-Pu; Chen, Ke-Neng

Shen, Lu-Yan; Fan, Meng-Ying; Dong, Bin; Yan, Wan-Pu; Chen, Ke-Neng.

Afiliação

Shen LY; Department of Thoracic Surgery I, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital and Institute, Beijing 100142, P.R. China.
Fan MY; Department of Thoracic Surgery I, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital and Institute, Beijing 100142, P.R. China.
Dong B; Department of Pathology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital and Institute, Beijing 100142, P.R. China.
Yan WP; Department of Thoracic Surgery I, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital and Institute, Beijing 100142, P.R. China.
Chen KN; Department of Thoracic Surgery I, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital and Institute, Beijing 100142, P.R. China.

Oncol Lett ; 14(4): 4835-4840, 2017 Oct.

Article em En | MEDLINE | ID: mdl-29085488

Palavras-chave

chemosensitivity; chemotherapy response; cisplatin; esophageal squamous cell carcinoma; homeobox C6; paclitaxel; tumor regression grade

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Oncol Lett Ano de publicação: 2017 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google